MILPHARM ApS — Credit Rating and Financial Key Figures
Credit rating
Company information
About MILPHARM ApS
MILPHARM ApS (CVR number: 35814159) is a company from SLAGELSE. The company recorded a gross profit of -1.9 kDKK in 2020. The operating profit was -1.9 kDKK, while net earnings were 175.7 kDKK. The profitability of the company measured by Return on Assets (ROA) was 22 %, which can be considered excellent and Return on Equity (ROE) was 33.3 %, which can be considered excellent. The equity ratio, a key indicator for solidity, stood at 46.8 %, a level that can be considered to be modest. This means a balanced mix of debt and equity financing its assets—a typical operational level for many companies. MILPHARM ApS's liquidity measured by quick ratio was 1.9 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.
Financial information
See financialsGross profit (kDKK)
EBIT (kDKK)
Profitability
Solidity
Key figures (kDKK)
See financials2016 | 2017 | 2018 | 2019 | 2020 | |
---|---|---|---|---|---|
Volume | |||||
Net sales | |||||
Gross profit | -6.76 | -7.67 | -8.12 | -9.65 | -1.87 |
EBIT | -6.76 | -7.67 | -8.12 | -9.65 | -1.87 |
Net earnings | -10.03 | -86.07 | 90.97 | 274.79 | 175.68 |
Shareholders equity total | 159.50 | 73.43 | 164.40 | 439.19 | 614.87 |
Balance sheet total (assets) | 372.48 | 279.46 | 474.32 | 921.34 | 1 313.47 |
Net debt | - 165.44 | -48.06 | - 170.36 | - 520.66 | - 669.95 |
Profitability | |||||
EBIT-% | |||||
ROA | 0.3 % | -2.2 % | 35.3 % | 52.0 % | 22.0 % |
ROE | -6.3 % | -73.9 % | 76.5 % | 91.1 % | 33.3 % |
ROI | 0.3 % | -2.2 % | 36.0 % | 55.6 % | 23.5 % |
Economic value added (EVA) | -5.21 | 4.32 | 2.60 | 7.88 | 22.72 |
Solvency | |||||
Equity ratio | 42.8 % | 26.3 % | 34.7 % | 47.7 % | 46.8 % |
Gearing | 125.0 % | 271.5 % | 183.4 % | 91.0 % | 104.7 % |
Relative net indebtedness % | |||||
Liquidity | |||||
Quick ratio | 1.7 | 1.4 | 1.5 | 1.9 | 1.9 |
Current ratio | 1.7 | 1.4 | 1.5 | 1.9 | 1.9 |
Cash and cash equivalents | 364.80 | 247.43 | 471.79 | 920.48 | 1 313.47 |
Capital use efficiency | |||||
Trade debtors turnover (days) | |||||
Net working capital % | |||||
Credit risk | |||||
Credit rating | BB | BB | BB | BBB | BBB |
Variable visualization
Companies in the same industry
- Professional credit risk reports
- Create your own estimates for any company
- Valuation analysis
- All 400,000+ Danish companies
- See instructions

... and more!
No registration needed.